(Q39439356)

12 September 2017

title

Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma. (English)

1 reference

12 September 2017

0 references

Nelson HS

1

1 reference

12 September 2017

Berkowitz RB

2

1 reference

12 September 2017

Tinkelman DA

3

1 reference

12 September 2017

Emmett AH

4

1 reference

12 September 2017

Rickard KA

5

1 reference

12 September 2017

Yancey SW

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

American Journal of Respiratory and Critical Care Medicine

12 September 2017

published in

1 reference

12 September 2017

volume

159

1 reference

12 September 2017

issue

5 Pt 1

1 reference

12 September 2017

page(s)

1556-1561

1 reference

The beta-agonist controversy

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Perspectives in beta 2-agonist therapy: vox clamantis in deserto vel lux in tenebris?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Beta-adrenergic agonist toxicity. Less of a problem, more of a perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Does tachyphylaxis occur to the non-pulmonary effects of salmeterol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Terbutaline-induced desensitization of human lymphocyte beta 2-adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Salmeterol tachyphylaxis in steroid treated asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

Twelve months, treatment with inhaled salmeterol in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.5.9807128

10.1164/AJRCCM.159.5.9807128

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference